DelveInsight’s Structural Heart Devices Market Insights Report 2032 provides the current and forecast market analysis, individual leading Structural Heart Devices Companies market shares, challenges, Structural Heart Devices Market Drivers, barriers, trends, and key market Structural Heart Devices companies in the market.
To read more about the latest highlights related to the Structural Heart Devices Market, get a snapshot of the key highlights entailed in the Market Report @ https://www.delveinsight.com/sample-request/structural-heart-devices-market-market
Key Takeaways from the Structural Heart Devices Market Report
- The Global structural heart devices market is expected to increase from USD 11,752.22 million in 2024 to USD 25,264.95 million by 2032, reflecting strong and sustained growth.
- The Global structural heart devices market is growing at a CAGR of 10.08% during the forecast period from 2025 to 2032.
- The leading Structural Heart Devices Companies such as Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc., Biomerics, Lepu Medical Technology (Beijing) Co., Ltd., LivaNova Inc., Comed B.V., TORAY, INDUSTRIES INC., Occlutech International AB, Microport Scientific Corporation, Meril Life Sciences Venus Medtech (Hangzhou) Inc., and others
- North America is anticipated to dominate the overall structural heart devices market. The region’s market growth is primarily driven by rising instances of structural heart conditions, including heart valve disease, congenital heart defects, and other cardiac abnormalities.
To know more about why North America is leading the market growth in the Structural Heart Devices Market, get a snapshot @ Structural Heart Devices Market Outlook
Structural Heart Devices Market Dynamics
The growing demand for structural heart devices is strongly driven by the rising incidence and prevalence of structural heart diseases, particularly heart valve disorders, congenital heart defects, and related conditions. According to DelveInsight analysis, in 2024, more than 500,001 individuals in Australia were diagnosed with heart valve disease, while an additional 250,002 cases remained undiagnosed, highlighting the scale of unmet clinical need. Similarly, in the UK, heart valve disease affected 11.29% of individuals aged 65 and older, underlining the impact of an aging population on disease burden. Globally, aortic valve stenosis has emerged as the most common valvular pathology, affecting an estimated 9 million people, with prevalence steadily rising due to increasing life expectancy and the growing incidence of atherosclerosis. In addition, aortic regurgitation, closely associated with diastolic hypertension, and mitral regurgitation, impacting nearly 24 million people worldwide, are further expanding the patient pool.
Structural Heart Devices Market Segmentation Analysis
This Structural Heart Devices Market report offers a comprehensive overview of the global structural heart devices, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Structural Heart Devices Market by Product Type (Repair Device [Occluders, Annuloplasty Devices, Valvuloplasty Devices, and Others] and Replacement device [Mechanical Heart Valves and Tissue Heart Valves]), Application (Atrial Septal Defect, Aortic Valve Stenosis, Patent Foramen Ovale, Ventricular Septal Defects, Mitral Regurgitation, and Others), End-User (Hospital, Ambulatory Surgical Centers, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing Structural Heart Devices Market.
Get a sneak peek at the Structural Heart Devices Market Dynamics @ Structural Heart Devices Market Dynamics Analysis
Structural Heart Devices Companies
Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc., Biomerics, Lepu Medical Technology (Beijing) Co., Ltd., LivaNova Inc., Comed B.V., TORAY, INDUSTRIES INC., Occlutech International AB, Microport Scientific Corporation, Meril Life Sciences Venus Medtech (Hangzhou) Inc., and others
Structural Heart Devices Market Drivers
The growth of the global structural heart devices market is primarily driven by the rising prevalence of cardiovascular and valvular disorders, such as aortic stenosis, mitral regurgitation, and congenital defects, which are creating a substantial need for advanced treatment solutions. Alongside this, technological advancements in structural heart devices, including next-generation transcatheter valves, mitral repair systems, and left atrial appendage closure devices, are enhancing durability, precision, and procedural safety while expanding the pool of eligible patients. Furthermore, the growing demand for minimally invasive cardiac interventions is accelerating adoption, as catheter-based procedures offer reduced surgical risks, shorter hospital stays, and faster recovery compared to traditional open-heart surgeries. Collectively, these drivers are positioning structural heart devices as an essential component of modern cardiovascular care, supporting strong market growth during the forecast period from 2025 to 2032.
Which MedTech key players in the Structural Heart Devices Market are set to emerge as the trendsetter explore @ Structural Heart Devices Key Players
Scope of the Structural Heart Devices Market Report
- Coverage- Global
- Forecast Period- 2025-2032
- Structural Heart Devices Companies- Medtronic, Boston Scientific Corporation, Braile Biomedica, JOTEC GmbH, Edwards Life Sciences Corporation, Valcare Medical, W. L. Gore & Associates, Inc., Abbott Laboratories, Cardiovascular Systems, Inc., XELTIS BV, JenaValve Technology, Inc., Biomerics, Lepu Medical Technology (Beijing) Co., Ltd., LivaNova Inc., Comed B.V., TORAY, INDUSTRIES INC., Occlutech International AB, Microport Scientific Corporation, Meril Life Sciences Venus Medtech (Hangzhou) Inc., and others
- Structural Heart Devices Market Key Factors Analysis
- Structural Heart Devices Impact Analysis, Regulatory Analysis
- Structural Heart Devices Market Porter’s Five Forces Analysis
Interested in knowing the Structural Heart Devices Market by 2032? Click to get a snapshot of the Structural Heart Devices Market Trends
Table of Contents
1. Structural Heart Devices Market Report Introduction
2. Structural Heart Devices Market Executive Summary
3. Competitive Landscape
4. Regulatory Analysis
5. Structural Heart Devices Market Key Factors Analysis
6. Structural Heart Devices Market Porter’s Five Forces Analysis
7. Structural Heart Devices Market Assessment
8. Structural Heart Devices Market Company and Product Profiles
9. KOL Views
10. Project Approach
11. About DelveInsight
12. Disclaimer & Contact Us
About Us
DelveInsight is a leading healthcare-focused market research and consulting firm that provides clients with high-quality market intelligence and analysis to support informed business decisions. With a team of experienced industry experts and a deep understanding of the life sciences and healthcare sectors, we offer customized research solutions and insights to clients across the globe. Connect with us to get high-quality, accurate, and real-time intelligence to stay ahead of the growth curve.
